ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AATG Albion Technology & General Vct Plc

68.00
0.00 (0.00%)
22 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Albion Technology & General Vct Plc LSE:AATG London Ordinary Share GB0005581672 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 68.00 66.50 69.50 68.00 68.00 68.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investors, Nec 7.68M 4.35M 0.0126 53.97 233.97M

Albion Technology & General VCT PLC: Interim Management Statement

26/11/2024 3:05pm

UK Regulatory


Albion Technology & Gene... (LSE:AATG)
Historical Stock Chart


From Nov 2024 to Jan 2025

Click Here for more Albion Technology & Gene... Charts.
Albion Technology & General VCT PLC: Interim Management Statement

Albion Technology & General VCT PLC
Interim Management Statement
LEI code: 213800TKJUY376H3KN16

Introduction
I present Albion Technology & General VCT PLC (the “Company”)’s interim management statement for the period from 1 July 2024 to 30 September 2024.

Performance and dividends
The Company’s unaudited net asset value (NAV) as at 30 September 2024 was £140.2 million or 73.63 pence per share (excluding treasury shares), a decrease of 1.46 pence per share (2.0%) since 30 June 2024.

A second dividend for the year ending 31 December 2024 of 1.88 pence per Ordinary share is to be paid on 6 December 2024 to shareholders on the register on 15 November 2024, resulting in total dividends of 3.68 pence per share for the year, a 5.1% yield on opening NAV.

Albion VCTs Mergers
On 12 November 2024, the Company issued a circular, jointly with the other Albion managed VCTs, proposing, amongst other things, the merger of the Company with Albion KAY VCT PLC and an offer for subscription (which is not conditional on the Merger being implemented).

The key reasons for the proposed mergers are the benefits it brings to shareholders including costs savings, simplified fee structure across the Albion VCTs, reduced administration and streamlined fundraising offers.

The circular includes a Notice of the General Meeting to be held at 11a.m. on 11 December 2024. The Company encourages all shareholders to vote on the resolutions to be proposed at the General Meeting in connection with the recommended proposals.

The circular can be viewed at www.albion.capital/mergers.

Fundraising
On 12 November 2024 the Company published a prospectus Top Up Offer of new Ordinary shares seeking to raise up to £20 million (before issue costs), with an overallotment facility of up to an additional £10 million. The Offers will open for applications on 6 January 2025. Further details can be found at www.albion.capital/offers.  

Portfolio
The following investments have been made during the period from 1 July 2024 to 30 September 2024:

Further investments£’000Activity
Infact Systems (T/A Infact)351Technology for credit assessment
Mondra Global303Food supply chain emissions modelling
Kennek Solutions264Vertical software for lenders
OpenDialog AI194AI powered chatbots and virtual assistants
DiffBlue190AI for code testing/writing platform
PeakData129Provides insights and analytics to pharmaceutical companies about therapeutic areas
Total further investments1,431 

Top ten holdings as at 30 September 2024:

InvestmentCarrying value
£’000
% of net asset valueActivity
Quantexa31,14722.2Network analytics platform to detect financial crime
Proveca6,6624.8Reformulation of medicines for children
Oviva5,5093.9A technology enabled service business in medical nutritional therapy (MNT)
Radnor House School (TopCo)4,9473.5Independent school for children aged 2-18
Runa Network3,4762.5Cloud platform and infrastructure that enables corporates to issue digital incentives and payouts
The Evewell Group3,3242.4Operator and developer of women’s health centres focusing on fertility
Panaseer3,2582.3Provider of cyber security services
Cantab Research (T/A Speechmatics)3,1222.2Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device
Chonais River Hydro2,8992.1Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands
Gravitee Topco (T/A Gravitee.io)2,4741.8API management platform

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/vct-funds/AATG.

Share buy-backs
During the period from 1 July 2024 to 30 September 2024, the Company purchased 1,100,970 shares for £749,000 (including stamp duty) at an average price of 67.66 pence per share. All of the shares were cancelled.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.

It is the Board’s intention for buy-backs to be at around a 5% discount to net asset value, so far as market conditions and liquidity permit.

Material events and transactions after the period end
Other than the circular and prospectus issued on 12 November 2024 as detailed above, there have been no other material events or transactions after the period end to the date of this announcement.

Further information
Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/vct-funds/AATG.

Clive Richardson, Chairman
26 November 2024

For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP
Telephone: 020 7601 1850


1 Year Albion Technology & Gene... Chart

1 Year Albion Technology & Gene... Chart

1 Month Albion Technology & Gene... Chart

1 Month Albion Technology & Gene... Chart